Filter By Industry
Filter By Tag

Newsroom

Price Vision Group Press releases

1 - 1 of 1 Press Release

Price Vision Group, First in Indiana to Treat Neurotrophic Keratitis with new FDA-Approved Drug
Feb 20, 2019
Dr. Matthew Feng of Price Vision Group will be the first ophthalmologist in Indiana to use the new FDA-approved drug, Oxervate™ (cenegermin). The patient, Tina Hunter, has vision loss due to neurotrophic keratitis (NK).


Price Vision Group RSS Feed